AKT1 and lung carcinoma: Quercetin‐chitosan nanoparticles (Qu‐CS‐NPs) demonstrated remarkable antitumor activities and effectively overcame the PTX resistance of lung cancer cells by inhibiting the AKT and ERK pathways.